Hexagon Bio

Hexagon Bio is a Menlo Park, California biotechnology company developing novel payloads for antibody-drug conjugates (ADCs) in oncology. The company designs next-generation ADC payloads intended to overcome resistance to current payloads and to expand the range of cancer indications ADCs can treat. Backed by SoftBank Vision Fund, Hexagon Bio operates a therapeutics pipeline and research platform rather than a public developer program: it publishes no API, SDK, or developer documentation surface. This profile was surfaced as a portfolio-company lead and enriched from Hexagon Bio's own public website (company, pipeline, science/platform, and news pages).

Hexagon Bio is profiled on the APIs.io network. Tagged areas include Company, Health Tech, Biotechnology, Oncology, and Antibody-Drug Conjugates.

Hexagon Bio’s developer surface includes engineering blog and 2 more developer resources.

🌐 Visit website 📡 Source on GitHub

3.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

CompanyHealth TechBiotechnologyOncologyAntibody-Drug ConjugatesDrug DiscoveryTherapeutics

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 3.8/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.4 / 17

Access Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/hexagon-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: hexagon-bio
name: Hexagon Bio
description: 'Hexagon Bio is a Menlo Park, California biotechnology company developing novel payloads for antibody-drug conjugates
  (ADCs) in oncology. The company designs next-generation ADC payloads intended to overcome resistance to current payloads
  and to expand the range of cancer indications ADCs can treat. Backed by SoftBank Vision Fund, Hexagon Bio operates a therapeutics
  pipeline and research platform rather than a public developer program: it publishes no API, SDK, or developer documentation
  surface. This profile was surfaced as a portfolio-company lead and enriched from Hexagon Bio''s own public website (company,
  pipeline, science/platform, and news pages).'
url: https://raw.githubusercontent.com/api-evangelist/hexagon-bio/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.hexagonbio.com/favicon.ico
x-type: company
x-source: vc-portfolio
x-backed-by:
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
x-website: https://www.hexagonbio.com
x-no-developer-surface: true
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Health Tech
- Biotechnology
- Oncology
- Antibody-Drug Conjugates
- Drug Discovery
- Therapeutics
apis: []
common:
- type: DomainSecurity
  url: security/hexagon-bio-domain-security.yml
- type: Website
  url: https://www.hexagonbio.com
- type: Blog
  url: https://www.hexagonbio.com/news/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

Hexagon Bio

Kin Score

Security Posture 1

Hexagon Bio Domain Security

Resources

Access & Security 1

Company 2

Source (apis.yml)